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ABSTRACT
Objectives: The objectives of the study were to determine the level of non-compliance with long-term glaucoma therapy in patients presenting in 
glaucoma department of Al-Shifa Trust Eye Hospital and to identify the health-seeking predictors affecting it.
Methods: A cross-sectional study of 5 months was conducted on glaucoma patients who are taking follow-up visits in glaucoma department for 
6 months or more. The level of compliance with glaucoma medication (dependent variable) was assessed through a scale at first and further 
transformed into binary variable afterward. Chi-square test of independence was used followed by logistic regression to find out the predictors of 
compliance.
Results: A total of 200 patients participated in the study. Majority of them were from urban background (n=125, 62.5%) and were diagnosed with 
glaucoma 1–5 years (n=104, 52%) back. Almost 16.00% of patients were not giving follow-up on given appointment. Moreover, 10.00% were not taking 
proper medications and prescribed dosage of medications was not taken by 21.5%. Intraocular pressure was higher than normal limits in 13.00%. 
Self-medication (χ2 (df) =5.44(1), 0.01, OR=0.28 (0.09–0.81) and doctor-patient communication (χ2(df)=18.25(1), 0.03, OR= 2.27 (1.06– 4.86) were 
significant health-seeking predictors of glaucoma treatment compliance.
Conclusion: Blindness due to glaucoma is an avoidable condition if underlying factors such as self-medication is discouraged and doctor-patient 
communication can be improved in the glaucoma department.
Keywords: Adherence, Socioeconomic determinants, Self-medication, Doctor-patient communication.
INTRODUCTION
Glaucoma is a condition in which unilateral or bilateral progressive 
optic neuropathy which is associated with visual field loss and may or 
may not be associated with raised intraocular pressure (IOP). Glaucoma 
is the second leading cause of blindness worldwide [1].
Globally, the prevalence of glaucoma is 64.3 million, which is expected 
to rise to 11.8 million by 2040. Africa and Asia are the two continents 
with the highest burden of glaucoma [2]. According to the World Health 
Organization, 5.2 million people are blind in the world due to glaucoma 
that makes up a total of 15% of the world’s blindness [3].
In South Asia, total glaucoma prevalence in 2013 was 3.54%. From 
2013 to 2040, South Asia is expected to record the steepest increase 
in the number of glaucoma cases as compared to other regions (17.06 
million to 32.90 million) [4].
Glaucoma is the 4th leading cause of blindness in Pakistan with the 
prevalence of 7.10% after cataract (66.00%), corneal opacity (12.60%), 
and refractive error (11.40%). There are more than 1.80 million 
glaucoma patients in Pakistan and almost half of them have lost their 
eyesight, due to delay in diagnosis and treatment [5]. Almost one million 
glaucoma patients were blind due to lack of awareness and expensive 
treatment in Pakistan [6].
Compliance in medical terms is defined as the act of following the 
recommendations of one’s medical practitioner [7]. The aim of 
glaucoma treatment revolves around maintaining the IOP to prevent 
optic nerve damage and loss of vision [8]. Medical compliance among 
glaucoma patients is poor and about 20% to 66% of them do not use 
their medication as directed [9].
Different studies have shown that there is high non-compliance with 
glaucoma therapy and different factors had been associated with non-
compliance in different areas of the world [10-13]. The most common 
reasons reported for non-compliance was asymptomatic nature of 
the disease [14] along with the factor of negligence [15]. The monthly 
income, the total expenditure towards the treatment, time required 
for one hospital visit including travel, stay, and loss of wages were also 
identified as determinants of compliance [16]. In addition, important 
component of health-care utilization is the health-seeking behavior 
(HSB). Needs factors such as physicians and patients view are the 
important mediator of HSB [17].
There is lack of comprehensive data in Pakistan regarding compliance to 
glaucoma treatment as well as there is no valid information that highlights 
the root causes of non-compliance with long-term glaucoma therapy with 
special consideration to health-seeking behavior. Treatment of glaucoma 
is incomplete without good patient compliance and adherence to the 
prescribed schedule. Adherence to treatment is now considered as an 
essential component of the glaucoma treatment as only a little carelessness 
can reverse the process and lead the patient to vision-threatening condition. 
Compliance can be made better if sufficient good quality data for the root 
causes of non-compliance are known. The objectives of the study were to 
determine the level of non-compliance with long-term glaucoma therapy in 
patients presenting in glaucoma department of Al-Shifa Trust Eye Hospital 
(ASTEH) and to identify the health-seeking predictors affecting it.
METHODS
A cross-sectional study was carried to assess the level of compliance as 
well as predictors of non-compliance in patients of long-term glaucoma 
therapy at the Glaucoma department, ASTEH, Rawalpindi, Pakistan.
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ASTEH is situated in Rawalpindi, one of the top five metropolitan 
cities of Pakistan [18]. The purpose of doing this study in this setting 
is based on the fact that this hospital is not only fully equipped with all 
the modern investigative facilities but also caters a large proportion of 
glaucoma confirmed and glaucoma suspect cases each year from every 
socioeconomic background.
All patients of glaucoma department were included in the study. Data 
were collected directly from patients over the duration of 5 months, 
starting from October 2018 to February 2019.
Non-probability consecutive sampling technique was adopted for 
data collection. All those patients who visiting glaucoma department 
for consultation during the study duration with follow-up visits of 
minimum 6 months (as an indicator of long-term therapy) and aged 
20 years and above were inducted. Patients who were presenting with 
other ocular comorbidities and those who have undergone recent 
glaucoma surgeries (<1 year) were excluded from the study.
The sample size was 196 but it was extended to 200 patients to 
overcome the chance of non-response rate. It was calculated by the 
means of OPEN-EPI software [19]. Prevalence of glaucoma was taken to 
be 15% based on the data of the WHO and was entered in the software 
at a confidence interval of 95% to calculate the sample size. The formula 
used for sample size calculation was:
Sample size n=[DEFF*Np(1-p)]/[(d2/Z21-α/2*(N-1)+p*(1-p)]
Data was collected by principal author using structured, interview-
based questionnaire which was translated in the Urdu language for 
better comprehension of participants. The dependent variable of this 
study was compliance with long-term glaucoma therapy. Compliance 
was assessed by four indicators, based on previous literature [19]. 
It included proper follow-up on given time, comparison between the 
medications prescribed and used, comparison between the prescribed 
and used dosage, and IOP checked on the day of examination under the 
supervision of ophthalmologist (Table 1).
Independent variables were divided into five sections: the first section 
consisted of patient’s basic information and included six questions. 
This was followed by a section of Socio-Economic questions (8). The 
third section had seven questions on ocular and medical history of the 
patient. The second last section had four questions on patient’s basic 
knowledge and understanding of disease and treatment regimen. The 
last section consisted of questions on patient’s overall satisfaction and 
family support (7). Of all these variables, five were taken as indicators 
of HSB for finding predictors of non-compliance based on previous 
literature [17,20-23].
The study was conducted after approval was taken from the Ethical 
Review Committee of Pakistan Institute of Ophthalmology. The 
collected data was entered on a daily basis in the statistical package 
for social sciences version 20. Data analysis was done in two phases; 
descriptive analysis followed by inferential statistics. Descriptive 
statistics were generated for all independent variables. Categorical 
data were presented in the form of frequencies and percentages. Valid 
percentages were reported in variables with missing data.
Chi-square test for independence variables was used for finding an 
association between outcome variable and independent variable. 
A significance level of 5% was used for all inferential statistics. The 
variables achieving statistical significance in univariate analysis were 
included in multivariate logistic regression analysis to identify the 
possible predictors of the outcome variable.
RESULTS
Background information
Majority of the cases had been suffering from glaucoma for <5 years 
(104, 52.00%) and 16 of the cases (8.00%) had glaucoma for more 
than 15 years. All the 200 respondents who participated in the 
study were age 20 years or above, and most of them were <50 years 
(n=106, 53.00%). Gender distribution demonstrated that males 
were predominant in the sample (n=114, 57.00%) as compared to 
females. Around one-fourth (n=53, 26.50%) of the respondents were 
illiterate, followed by 45 (22.50%) with only primary education. 
Among all the respondents, 48 (24.00%) were unmarried. Most of 
the respondents were from urban background (n=125, 62.50%) 
(Table 2).
Half (n=100, 50.00%) of the respondents were dependent on their 
family members for fulfilling their basic needs and almost same 
number (n=98, 49.00%) of respondents were sole earners of their 
whole family. Forty percent of the working lot had private jobs (n=80) 
and low family income (<30k) reported by almost two-third (n=123, 
61.50%) of participants.
Almost half of the participants do not consider their glaucoma 
treatment as affordable (n=86, 43.00%). This was because of the 
indirect expenses as large proportion (n=171, 85.50%) of glaucoma 
patients used a public transport as a mode to reach the health facility 
for treatment and 177 (88.50%) of the total cases reported that the 
expense of one visit to hospital was ranging from USD 6–12. Moreover, 
42.00% (n=84) respondents said that the single time purchase of their 
medications is between USD 7–12 (Table 3).
Glaucoma is affecting greater number of females (n=14, 53.80%) as 
compared to their counterparts for 11–15 years. Bargraph of both 
genders in relation with duration of glaucoma are shown in Fig. 1.
As far as ocular and medical history is concerned, 130 respondents 
(65.00%) came for examination because of their scheduled 
appointment, followed by 70 (35.00%) with other complaints that are 
given in Table 4. One-fourth of the participants had not undergone any 
Table 1: Category of compliance
Level of compliance Condition Scale
Patient compliant Fulfilling all the four 
indicators
4
Patient non-compliant Not fulfilling any one 
indicator
1, 2, 3
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ocular surgical procedure (n=55, 27.50%) and twenty-six (13.00%) 
respondents had a positive history of ocular trauma.
Almost half (n=89, 44.50%) respondents accepted self-medication 
(traditional methods) as their first treatment choice for glaucoma-
related ocular issues, before diagnosis. Eight (4.00%) glaucoma 
patients said that they do not know if anyone had glaucoma in their 
family previously. A total of 115 (57.50%) glaucoma patients were co-
morbid with 73 (36.50%) reporting hypertensive and 42 (21.00%) of 
them reporting being diabetic.
Total compliance of the patients was extracted based on following four 
variables. Around1/4th of the patients responded that they do not take 
proper dosage of the medication on prescribed time (n=43, 21.50%). 
Thirteen percent (n=26) were not having IOP in the normal range when 
checked at the time of data collection. Almost 10% (n=19) patients 
were not even using the prescribed medications and 31 (15.50%) were 
not taking follow up on the given appointment (Table 5).
The composite outcome for above variables represented the level of 
compliance with glaucoma therapy and is shown in the Fig. 2.
More than 15% (n=35, 17.50%) of the respondents were not aware of 
the cause for their vision loss. More than half of respondents (n=109, 
54.50%) reported that their eye medication do not fully control 
the disease. In addition, 40 (20.00%) respondents said that they 
had confusion regarding schedule of prescribed medications with 
24 (60.00%) reported the high (more than one) number of medicines 
per dose to be the cause for confusion (Table 6).
Seventy-three (36.50%) patients were not satisfied with 
their doctor-patient communication and same percentage of patients 
reported ocular side effects with the treatment regimen that they were 
currently using. More than 20% (n=45, 22.50%) of the participants 
reported that they spent 4–6 h on a single visit to the hospital. Patients 
also said that they face difficulty in instilling drops to their eyes (n=30, 
15.00%) with only 83 (41.50%) visiting the hospital in the presence of 
helper/attendant.
Patients found no benefit of the treatment to their vision or their 
disease status (n=76, 38.00%). Nearly same frequency (n=77, 38.50%) 
of patients said that they are not satisfied with the treatment (Table 7).
Association of HSB related variables with outcome
Chi-square test of independence was carried out to check association of 
compliance with independent variables. Out of total 159 patients who 
had never used self-medication(traditional methods) as first treatment 
choice for glaucoma-related ocular issue, 32.07% were non-compliant 
with glaucoma treatment. Pearson chi-square (χ2 [df]=5.44 [1], 
p=0.020) showed that there was a significant association between level 
of compliance and practice of self-medication.
Patient satisfaction played a major role in increasing compliance of the 
patient to treatment regimen. Patients (n=127) who agreed that their 
doctor informed them everything about the treatment and prognosis 
of their condition were found more compliant (n=105, 82.70%) as 
compared to their un-agreeing counterparts (p<0.050). Similarly, 
overall satisfaction, perceived benefit, and knowledge about eye drops 
also showed a significant association (Table 8).
Predictors of compliance to glaucoma treatment
In multivariate analysis, the multiple regression model was constructed 
by utilizing all the five variables of health-seeking behavior as they 
all were found statistically significant during univariate analysis. The 
overall model explained 18.90% (Cox & Snell R2=0.189) to 27.30% 
(Nagelkerke R2=0.273) of the variation in outcome variable and was 
statistically significant (χ2 (df)= 41.97 (5), p=0.010). It was observed that 
patients who did self-medication has 0.28 times (p=0.01, 0.09– 0.81) 
less compliance as compared to those who didn’t. Information about 
the treatment regimen by physician was also a statistically significant 
predictor of glaucoma compliance, as individuals who had good 
awareness about the treatment duration and their prognosis were 
2.27 times (p=0.030) more likely to be compliant with the glaucoma 
therapy than their less knowledgeable fellows. Satisfaction with the 
glaucoma treatment, perceived benefit of the treatment, and knowledge 























Duration of glaucoma (years) 
Male
Females
Fig. 1: Duration of glaucoma with gender
Table 3: Socio-economic status of the respondents
Socio-economic status Descriptive
n %
Earning members of 
family
Sole earner 98 49.00
2 members 70 35.00
3 members 32 16.00
Cost of medication
USD 2–6 116 58.00
USD 7–12 84 42.00
Transport to hospital
Personal transport 23 11.50
Public transport 171 85.50
Private transport 6 3.00
Expense of one visit




Not affordable 86 43.00









Low income (<30K) 123 61.50





















Fig. 2: Percentage of compliance in patients
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significant in final multivariate analysis. Detailed information regarding 
the multivariate analysis is available in Table 9.
DISCUSSION
The main objectives of the study were to determine the level of non-
compliance in long-term glaucoma therapy and associated predictors 
in patients visiting tertiary eye care hospital.
There were two major predictors of non-compliance in the current 
study. The first is doctor-patient communication. It includes the 
information provided to the patient by their physician about 
the duration and schedule of treatment regimen. The study has 
shown that patients who were well-aware and properly guided 
by their doctor were 2.27 times (p=0.030) more likely to be 
compliant as compared to the ones who were not well informed 
by their physicians. Alan and Robert stated that proper glaucoma 
management demands patients’ adherence to therapy and is more 
likely to happen when the treatment regimen is simplified and well 
translated to the patient [24]. Similarly, Rubin Spann also said that 
poor communication between doctor and patient is a reason for 
patient’s non-compliance to treatment plan [25]. Similar findings 
were reported by Taylor et al. in a qualitative study where patients 
reported good communication with their physicians as a triggering 
factor for taking glaucoma seriously and the following treatment 
properly [26]. Many other studies are also in agreement with the 
current study in stating that explanation of treatment by the doctor 
can positively affect the compliance of treatment [27-31].
Almost 30% were found to be non-compliant with the long-term 
glaucoma therapy. This is alarming as it shows that one in every three 
person is non-compliant to treatment. This is in agreement with de 
Castro et al. review in which the non-compliance of long-term glaucoma 
therapy ranged between 4.60% up to 59.00% [32]. The study by Abu 
Hussein et al. showed more non-compliance (53.60%) than the current 
study in an Egyptian population [11].
Twenty-one percent of patients (n=43) were not following proper 
schedule of their prescribed regiment and almost same percentage 
(20.10%) of respondents said that they have confusion regarding 
schedule of medication. Most of the patients (65.00%) said that 
the reason for confusion was handling of multiple medications per 
day which is in agreement to Cook et al. where greater doses per 
day were the strongest predictor for non-adherence to glaucoma 
Table 4: Frequency of ocular and medical history
Variable n %
Reason for visiting 
hospital




History of ocular surgery
No 55 27.50
Yes 145 72.50






Family history of 
glaucoma
No 141 70.50








Don’t Know 9 4.50
Yes 42 21.00
Table 5: Composite outcome variable (compliance)
Variables n (%)























If yes, what is the reason of confusion
Inability to read prescription 11 27.50
Due to more than one medicines 24 60.00
Others 05 12.50
















Perceived benefit of treatment
No 76 38.00
Yes 124 62.00
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therapy [33]. This was followed by 35.00% in this study who 
reported that they find difficulty in reading the prescription due to 
poor visual status.
Almost 30% of the respondents were not having IOP within normal 
range in the current study. Thirty-one patients (15.50%) reported 
that they are not visiting the hospital (follow up) on their respective 
appointment time followed by 19 (9.50%) of them saying that they are 
not using all the medications. This is tragic as such negligence on the 
patient’s side can nullify the beneficial effect of the treatment regimen 
and all the efforts to decrease the visual loss will go in vain as stated by 
Denis where medical adherence was reported to be crucial for effective 
glaucoma treatment [34].
A large number of patients reported stinging (15.50%), burning 
(11.00%), and itching (10.00%) as the side effects of the long-term 
glaucoma therapy. This is in agreement with the study by Baloch et al. 
where side effects from treatment were the cause for poor adherence to 
glaucoma therapy [30].
Basic knowledge of patients about their disease was found to be poor 
as almost 20% of the patients responded that they were not familiar 
with their ocular condition. Almost one third (47.50%) of the patients 
were confused whether glaucoma medications could completely end 
their disease followed by only 14 patients who were certain that their 
disease could not be ended up completely by glaucoma medications. 
Knowledge about eye drops was found out to be statistically significant 
with compliance level (p<0.050) in the current study.
Living with chronic diseases is a challenge in its self without enough family 
support. This was assessed in the current study by proxy indication of the 
presence of attendant with the patient in the hospital where more than half 
of the patients (58.50%) were alone indicating that the family members 
take the disease and regular follow-ups of the patient for granted and/or 
as part of the routine, or it may be because they have jobs and could not 
make days off for every follow-up. They do not pose importance to patient’s 
restrictive visual field and utmost need of the guide in patient’s orientation 
and mobility. A Korean study by Yoo et al. showed statistically significant 
association of family support with glaucoma medication compliance [35].
Table 8: Determinants of compliance with treatment
Determinants Compliance χ2 (df) p-value Phi




51 (32.07) 5.44 (1) 0.020 0.17





22 (17.32) 18.25 
(1)
0.001 0.31
No 39 (53.42) 34 (46.57)
Knowledge about eye drops
Yes 78 (85.71) 13 (14.28) 15.57 
(1)
0.001 0.27
No 66 (60.55) 43 (39.44)




19 (15.32) 24.38 
(1)
0.001 0.36




18 (14.63) 26.61 (1) 0.001 0.37
No 39 (50.64) 38 (52.05)
Table 9: Predictors of compliance with glaucoma therapy






No 108 (67.92) 51 (32.07) 5.44 (1) 0.01 0.28 (0.09–0.81)
Yes 36 (87.80) 05 (12.19) 1
Knowledge about eye drops
Yes 78 (85.71) 13 (14.28) 15.57 (1) 0.58 1
No 66 (60.55) 43 (39.44) 1.29 (0.51–3.24)
Doctor-patient 
communication
Yes 105 (82.67) 22 (17.32) 18.25 (1) 0.03 1
No 39 (53.42) 34 (46.57) 2.27 (1.06–4.86)
Perceived benefit of 
treatment
Yes 105 (84.67) 19 (15.32) 24.38 (1) 0.55 1
No 39 (51.31) 37 48.68 1.42 (0.43–4.66)
Overall satisfaction
Yes 105 (85.36) 18 (14.63) 26.61 (1) 0.06 1
No 39 (50.64) 38 (52.05) 2.87 (0.92–8.96)
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This study was one of its kind in finding out adherence to glaucoma 
treatment. It has not only relied on the patient’s response for checking 
the level of non-compliance but also has taken the readings of IOP to 
correlate the patient’s response. The limitations of the study were 
that the detailed factors for non-compliance or the underlying factors 
for shift in IOP could not be reached out because of shortage of time. 
Moreover, this study was performed only in hospital setting which 
could have masked few facts like observing the presence and proper 
use of prescribed medication. More glaucoma centers should be made 
to reduce patient burden and increase the patientdoctor sitting time. 
Large-scale studies are required to figure out the reasons for non-
compliance and overcoming those to beat this avoidable silent killer of 
vision (Glaucoma), thus ensuring efficient use of Healthcare resources 
for the betterment of Public Good.
CONCLUSION
Almost 30% of the respondents showed non-adherence to glaucoma 
therapy. Knowledge of the disease and lack of satisfaction with 
treatment were significant factors. However, poor communication with 
the doctor and self-medication were predictors of non-compliance.
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